KALA
KALA
NASDAQ · Biotechnology

Kala Bio Inc

$0.45
-0.03 (-5.34%)
As of Sep 28, 10:40 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,385.6% upside
Low Target $8.32
Average Target $11.19
High Target $14.48
Current Price $0.45
Current
$0.45
Target
$11.19
$8.32 $11.19 avg $14.48
Scenario Analysis
Bear Case
$8.32
1,748.1%
Low target
Base Case
$11.19
+2,385.6%
Avg target
Bull Case
$14.48
+3,116.3%
High target
Risk/Reward
1.8x
Balanced
Price in Context
Target vs 52W High
$11.19
-98.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%